Xilio Development Inc (XLO)

Currency in USD
0.650
+0.001(+0.15%)
Closed·
After Hours
0.651+0.001(+0.17%)
·
XLO Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Trading near 52-week Low
Fair Value
Day's Range
0.6150.657
52 wk Range
0.6151.700
Key Statistics
Prev. Close
0.649
Open
0.64
Day's Range
0.615-0.657
52 wk Range
0.615-1.7
Volume
666.69K
Average Volume (3m)
1.33M
1-Year Change
-31.58%
Book Value / Share
0.21
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
XLO Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
0.000
Downside
-100.00%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year

Xilio Development Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Xilio Development Inc Company Profile

Xilio Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of tumor-activated immuno-oncology therapies. The company’s checkpoint inhibitor program includes XTX101, an investigational Fc-enhanced, tumor-activated anti-CTLA-4 mAb that is in Phase 2 clinical trial for patients with advanced solid tumors. It also develops cytokine programs, which comprises XTX202, a tumor-activated beta-gamma biased IL-2, currently under Phase 2 clinal trials; and XTX301, an investigational tumor-activated, engineered IL-12 molecule, currently under Phase 1 studies. The company was founded in 2016 and is headquartered in Waltham, Massachusetts.

Compare XLO to Peers and Sector

Metrics to compare
XLO
Peers
Sector
Relationship
P/E Ratio
−0.6x−4.1x−0.5x
PEG Ratio
−0.01−0.170.00
Price/Book
3.1x2.1x2.6x
Price / LTM Sales
3.6x9.7x3.2x
Upside (Analyst Target)
-60.4%45.7%
Fair Value Upside
Unlock23.0%8.6%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 0.000

Earnings

Latest Release
May 08, 2025
EPS / Forecast
-0.18 / 0.19
Revenue / Forecast
2.90M / 23.90M
EPS Revisions
Last 90 days

XLO Income Statement

People Also Watch

25.91
CNC
-0.61%
39.04
SU
-1.06%
52.460
ASTS
-1.34%
193.33
LULU
-3.59%
8.680
CDE
-0.12%

FAQ

What Stock Exchange Does Xilio Development Trade On?

Xilio Development is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Xilio Development?

The stock symbol for Xilio Development is "XLO."

What Is the Xilio Development Market Cap?

As of today, Xilio Development market cap is 33.66M.

What Is Xilio Development's Earnings Per Share (TTM)?

The Xilio Development EPS (TTM) is -0.83.

When Is the Next Xilio Development Earnings Date?

Xilio Development will release its next earnings report on 05 Aug 2025.

From a Technical Analysis Perspective, Is XLO a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Xilio Development Stock Split?

Xilio Development has split 0 times.

How Many Employees Does Xilio Development Have?

Xilio Development has 64 employees.

What is the current trading status of Xilio Development (XLO)?

As of 02 Aug 2025, Xilio Development (XLO) is trading at a price of 0.65, with a previous close of 0.65. The stock has fluctuated within a day range of 0.62 to 0.66, while its 52-week range spans from 0.62 to 1.70.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.